ZNTL
Zentalis Pharmaceuticals, Inc. · Healthcare
Director Cam Gallagher sold $1.2M of Zentalis Pharmaceuticals, Inc.
Sold$1,231,238
$43.40Price
28,369Shares
−5%Stake
What ZNTL did after the filing
- The stock from Tue, Apr 6 close, $43.04
- +30.4%
- S&P 500, same days
- +1.4%
Measured over 30 trading days, to the May 18 close.
Traded Mon, Apr 5. Filed Tue, Apr 6, 1:48 PM ET, during the session. Returns use the Apr 6 close and the May 18 close. Not investment advice.